Illustrative image – not actual.Chennai-based Shasun Pharmaceuticals has signed a Letter of Intent (LoI) with Bangalore-based pharmaceutical firm, SeQuent Scientific, for a veterinary products business.
The LoI has been signed to develop, manufacture and sell veterinary products including active pharmaceutical ingredients (API). As per the agreement, both the companies together will set up a JV company. In the JV, SeQuent will hold 73 per cent shares and the remaining 27 per cent shares will be held by Shasun. Contributions will be made by both the companies by way of transfer of identified assets, contracts and licences. The JV company is expected to be ready for operation by March 2014, subject to the requisite corporate and statutory approvals.
The JV firm will have a manufacturing facility in Vishakhapatnam where Shasun is currently developing its manufacturing facilities.
Shasun Pharma currently produces active pharmaceutical ingredients and formulations and offers contract research and manufacturing service for APIs in India and the UK. Through this, JV Shasun will foray into the veterinary medicine segment.
